newsfilter
← Latest News
ACCESS Newswire·

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

KELOWNA, BC / ACCESS Newswire / December 30, 2025 / Lexaria Bioscience Corp. , a global innovator in drug delivery platforms, provides the following additional